| 标题 |
[高分]
Adis Drug Report: Anti-ADAM9 Antibody-drug conjugate DB 1317 (Duality Biologics) |
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 |
22 Oct 2025 Pharmacodynamic, pharmacokinetic and adverse events data from a preclinical trial in Solid tumours presented at the International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2025) 23 Sep 2025 Phase-I clinical trials in Solid tumours (Inoperable/Unresectable, Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA, Australia (IV) (NCT07141706) 26 Aug 2025 DualityBio plans a phase I trial for Solid tumors (Inoperable/Unresectable; Late-stage disease; Metastatic disease; Second-line therapy or greater) in the US and Australia (IV) in September 2025 (NCT07141706) |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)